Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Sesen Bio Inc (SESN)

Sesen Bio Inc (SESN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Sesen Bio Inc 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 USA

www.sesenbio.com P: 617-444-8550

Description:

Sesen Bio Inc. is a late-stage company developing next-generation antibody-drug conjugate therapies for patients with cancer. The company's product portfolio includes Vicinium(TM) which is in its clinical trial, treats high-grade non-muscle invasive bladder cancer. Sesen Bio Inc., formerly known as Eleven Biotherapeutics, is based in Massachusetts, United States.

Key Statistics

Overview:

Market Capitalization, $K 127,956
Enterprise Value, $K -59,964
Shares Outstanding, K 203,492
Annual Sales, $ 40,000 K
Annual Net Income, $ -19,880 K
Last Quarter Sales, $ 40,000 K
Last Quarter Net Income, $ 20,460 K
60-Month Beta 0.83
% of Insider Shareholders 3.20%
% of Institutional Shareholders 16.45%
Float, K 196,980
% Float 96.80%
Short Volume Ratio 0.62

Growth:

1-Year Return 5.26%
3-Year Return -0.52%
5-Year Return -41.23%
5-Year Revenue Growth 9,202.33%
5-Year Earnings Growth 104.50%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.04 on 02/28/23
Latest Earnings Date 02/27/23
Earnings Per Share ttm 0.11
EPS Growth vs. Prev Qtr -128.57%
EPS Growth vs. Prev Year -300.00%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-20 on 03/08/23

SESN Ratios

Ratio
Price/Earnings ttm 11.72
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 6.70%
Return-on-Assets % 5.41%
Profit Margin % -49.70%
Debt/Equity 0.00
Price/Sales 2.98
Price/Cash Flow 3.39
Price/Book 0.81
Book Value/Share 0.83
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar